Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

breast radiologist breast cancer mammography

Metastatic breast cancer survival rates are up in Medicaid expansion states

A JAMA Oncology study found a decrease in two-year mortality rates between 2010 and 2015, attributing the findings to a 2014 Medicaid expansion.

Thumbnail

O-RADS externally validated for differentiating between benign and malignant ovarian lesions

In addition to O-RADS external validation, experts also sought to determine if incorporating acoustic shadowing as a benign finding would improve diagnostic performance. 

Experts evaluate new consensus recommendations involving rare cancer on CT

Researchers referred to the newly developed Korean Society of Abdominal Radiology consensus recommendations when evaluating the CT scans of patients with extrahepatic bile duct cancer.

Algorithm performs at expert level when distinguishing between benign and malignant ovarian tumors

Experts involved with the study suggested that these findings could be beneficial in the future of ovarian tumor assessment by providing clinical decision making support.

lung cancer pulmonary nodule

Pre-treatment chest CT features can predict overall survival in lung cancer patients

The noncancerous imaging features obtained before radiation therapy could be used in the future to help guide treatment decisions for these patients, experts suggested.

breast cancer screening mammography

DBT-based radiomics nomogram predicts lymphovascular invasion in breast cancer patients

The DBT-based combined radiomic nomogram achieved a specificity of nearly 95% when predicting lymphovascular invasion, which was higher than other clinical predictive models. 

prostate cancer PSA

Combination therapy that includes new radionuclide proves effective for metastatic prostate cancer

The therapeutic combination of 177Lu-PSMA-617 with idronoxil (NOX66) reduced PSA levels in 86% of study participants.

Thumbnail

'Surprising' decline in annual screening among breast cancer survivors has experts concerned

The downward trend in annual mammography adherence should serve as a call to action for new processes to engage breast cancer survivors, physicians urged.